
1. travel med infect dis. 2019 may - jun;29:48-50. doi: 10.1016/j.tmaid.2019.03.004.
epub 2019 mar 11.

clinical predictors mortality middle east respiratory syndrome coronavirus 
(mers-cov) infection: cohort study.

alfaraj sh(1), al-tawfiq ja(2), assiri ay(3), alzahrani na(4), alanazi aa(4),
memish za(5).

author information: 
(1)corona center, prince mohamed bin abdulaziz hospital, ministry health,
riyadh, saudi arabia; infectious diseases division, department pediatrics,
prince mohamed bin abdulaziz hospital, ministry health, riyadh, saudi arabia; 
university british columbia, vancouver, bc, canada.
(2)speciality internal medicine unit quality department, johns hopkins aramco
healthcare, dhahran, saudi arabia; department medicine, indiana university
school medicine, indianapolis, in, usa; department medicine, johns hopkins 
university school medicine, baltimore, md, usa.
(3)critical care department, prince mohammed bin abdulaziz hospital, ministry 
health, saudi arabia.
(4)corona center, prince mohamed bin abdulaziz hospital, ministry health,
riyadh, saudi arabia.
(5)college medicine, alfaisal university, riyadh, saudi arabia; infectious
diseases division, department medicine, department research, prince mohamed
bin abdulaziz hospital, ministry health, riyadh, saudi arabia; hubert
department global health, rollins school public health, emory university,
atlanta, ga, usa. electronic address: zmemish@yahoo.com.

background: since emergence middle east respiratory syndrome
coronavirus (mers-cov) 2012, virus caused high case fatality rate.
the clinical presentation mers varied asymptomatic severe bilateral
pneumonia, depending case definition surveillance strategies. there
are studies examining mortality predictors disease. this
study, examined clinical predictors mortality middle east respiratory
syndrome (mers) infection.
methods: retrospective analysis symptomatic admitted patients a
large tertiary mers-cov center saudi arabia period april 2014 to
march 2018. clinical laboratory data collected analysis done
using binary regression model.
results: total 314 symptomatic mers-cov patients included the
analysis, mean age 48 (±17.3) years. cases, 78 (24.8%) died.
the following parameters associated increased mortality, age, wbc,
neutrophil count, serum albumin level, use continuous renal replacement
therapy (crrt) corticosteroid use. odd ratio mortality highest
for crrt corticosteroid use (4.95 3.85, respectively). use of
interferon-ribavirin associated mortality cohort.
conclusion: several factors contributed increased mortality cohort 
mers-cov patients. factors, use corticosteroid crrt 
most significant. studies needed evaluate whether factors
were mark severe disease actual contributors higher mortality.

copyright © 2019. published elsevier ltd.

doi: 10.1016/j.tmaid.2019.03.004 
pmcid: pmc7110962
pmid: 30872071  [indexed medline]

